Phosphorylated and non-phosphorylated forms of catechol O-methyltransferase in rat liver, brain and other tissues

被引:17
作者
Overbye, Anders [1 ]
Seglen, Per O. [1 ]
机构
[1] Norwegian Radium Hosp, Rikshosp, Univ Hosp, Inst Canc Res,Dept Cell Biol,Prote Sect DNR, N-0310 Oslo, Norway
关键词
catechol O-methyltransferase (COMT); N-acetylation; phosphorylation; proteomics; tissue distribution; two-dimensional gel electrophoresis; FUNCTIONAL POLYMORPHISM; CRYSTAL-STRUCTURE; EXPRESSION; VARIANT; ENZYME; GENE; ASSOCIATION; INHIBITION; ESTRADIOL; MEMBRANES;
D O I
10.1042/BJ20081284
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Seven different forms of the enzyme (COMT(catechol O-methyltransferase) were found in isolated rat hepatocytes by two-dimensional get electrophoresis and irm-nuinoblotting: five small variants (S-COMT) and two large variants (L-COMT). The identities of these COMT forms were verified by tryptic fingerprinting using MALDI-TOF (matrix-assisted laser desorption ionization-time-of-flight) MS, and by amino acid sequencing-using ESIIT-MS/MS (electrospray ionization with ion-trap tandem MS). Analysis of tissue distributions showed that the S-COMT forms were highly expressed in liver and kidney, whereas L-COMT was expressed more strongly in other tissues. Both of the L-COMT forms were found in all of the tissues examined except the heart, which expressed only the most acidic form, and the kidney, which expressed only the most basic form. Subcellular fractionation revealed the presence of both S-COMT and L-COMT in soluble, as well as sedimentable, fractions, suggesting that they Should be classified by size rather than (as previously) by localization. Several of the S-COMT forms were N-acetylated, and the two most acidic forms were found to be phosphorylated at Ser(260). One of the fatter was unique to liver cells; the other was also found in kidney, brain and thymus. Among the non-phosphorylated S-COMT forms, one was ubiquitous, One was found ill testis and liver, and a third was found in liver, kidney and thymus. No other phosphorylated sites were found, suggesting that the pl differences distinguishing between the various COMT forms arc due to some as yet unidentified structural modification(s).
引用
收藏
页码:535 / 545
页数:11
相关论文
共 42 条
[1]  
AXELROD J, 1958, J BIOL CHEM, V233, P702
[2]   HUMAN CATECHOL-O-METHYLTRANSFERASE - CLONING AND EXPRESSION OF THE MEMBRANE-ASSOCIATED FORM [J].
BERTOCCI, B ;
MIGGIANO, V ;
DAPRADA, M ;
DEMBIC, Z ;
LAHM, HW ;
MALHERBE, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) :1416-1420
[3]   Sequence and structure-based prediction of eukaryotic protein phosphorylation sites [J].
Blom, N ;
Gammeltoft, S ;
Brunak, S .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 294 (05) :1351-1362
[4]   Catechol-O-methyltransferase and its inhibitors in Parkinson's disease [J].
Bonifacio, Maria Joao ;
Palma, P. Nuno ;
Almeida, Luis ;
Soares-da-Silva, Patricio .
CNS DRUG REVIEWS, 2007, 13 (03) :352-379
[5]   Kinetics and crystal structure of catechol-O-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application [J].
Bonifácio, MJ ;
Archer, M ;
Rodrigues, ML ;
Matias, PM ;
Learmonth, DA ;
Carrondo, MA ;
Soares-da-Silva, P .
MOLECULAR PHARMACOLOGY, 2002, 62 (04) :795-805
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   MOLECULAR IMMUNOCYTOCHEMISTRY OF THE CUZN SUPEROXIDE-DISMUTASE IN RAT HEPATOCYTES [J].
CHANG, LY ;
SLOT, JW ;
GEUZE, HJ ;
CRAPO, JD .
JOURNAL OF CELL BIOLOGY, 1988, 107 (06) :2169-2179
[8]   Catechol-O-methyltransferase:: variation in enzyme activity and inhibition by entacapone and tolcapone [J].
De Santi, C ;
Giulianotti, PC ;
Pietrabissa, A ;
Mosca, F ;
Pacifici, GM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) :215-219
[9]   Fragmentation of phosphopeptides in an ion trap mass spectrometer [J].
DeGnore, JP ;
Qin, J .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 1998, 9 (11) :1175-1188
[10]   Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeutics [J].
Diaz-Asper C.M. ;
Weinberger D.R. ;
Goldberg T.E. .
NeuroRX, 2006, 3 (1) :97-105